APPLICATIONS PUBLISHED 15 DECEMBER 2004
Published: 1-Sep-2005
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Compsn having gelling properties for the prolonged drug delivery of bioactive substances
Ethypharm 1485066*
Materials containing multiple layers of vesicles
Novartis 1485067*
HGH (human growth hormone) formulations for pulmonary administration
Advanced Inhalation Research 1485068*
Method and apparatus for producing dry particles
Advanced Inhalation Research 1485069*
Pharmaceutical microparticles
Novartis 1485070*
Compressed tablets comprising microparticles with modified release
Flamel Technologies 1485071*
Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved adhesion
LTS Lohmann Therapie-Systeme 1485072*
Method for administration of growth hormone via pulmonary delivery
Advanced Inhalation Research; Eli Lilly 1485073*
Compsns for treating digestive functional disorders
Rytek 1485074*
MHC-peptide complex binding ligands
Dyax Corp; Technion Research & Development Foundation 1485075*
Therapeutic methods for acute myeloid leukemia
The Ohio State University Research Foundation 1485076*
Drug combination therapy
Merck 1485077*
NE and 5-HT reuptake inhibitors for treating visceral pain syndromes
Cypress Bioscience; Rao, Srinivas 1485078*
Small molecule entry inhibitors
Tibotec Pharmaceuticals 1485079*
Use of adapalene for the treatment of dermatological disorders
Galderma Research & Development 1485080*
Ibuprofen solution for hard shell capsules
Warner-Lambert 1485081*
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compsns thereof
Xenoport 1485082*
Dexanabinol and dexanabinol analogues regulate inflammation related genes
Pharmos Corp 1485083*
Use of an L-ascorbic acid salt to prepare a pharmaceutical compsn for ophthalmic topical use capable of improving the level of L-ascorbic acid in the eye
Aziende Chinche Riunite Angelini Francesco 1485084*
Phosphate prodrugs of fluorooxindoles
Bristol-Myers Squibb 1485085*
Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane as NMDA, 5HT3, and neuronal nicotinic receptor antagonists
Merz Pharma 1485086*
(+)-2-1-(3-ethoxy-4-methoxyphenyl_-2-methylsulphonylethyl)-4-acetylaminoisoindole-1,3-dione; methods for using and compsns thereof
Celgene 1485087*
Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
The Curators of the University of Missouri 1485088*
Combination treatments for chemokine-mediated diseases
Schering 1485089*
Combinations comprising epothilone derivatives and alkylating agents
Novartis 1485090*
Thirazolidine oxazole derivatives that modulate PPAR activity
Warner-Lambert 1485091*
Use of rapamycin for inhibiting of cell death
Wyeth 1485092*
Di-aryl substituted tetrazole modulators of metabotropic glutamate receptors
Merck 1485093*
Form of presentation for 3-(2--4-(hexyloxycarbonylamino-imino-methyl)-phenylamino-methyl-1-methyl-1-H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino)-propionic acid ethyl ester to be administered orally
Boehringer Ingelheim Pharmaceuticals 1485094*
Fluorinated 4-azasteroid derivatives as androgen receptor modulators
Merck 1485095*
Methods for preventing or treating cardiac arrhythmia
Chantest 1485096*
Crystalline forms of gatifloxacin and processes for preparation
Teva Pharmaceutical Industries 1485097*
Pharmaceutical compsns comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulphonyl-phenyl)-pyrazolo[1,5-B]pyridazine in nanoparticulate form
Glaxo Group 1485098*
Inhibitors of histone deacetylase
Janssen Pharmaceutica 1485099*
Azinylaminoazoles as inhibitors of protein kinases
Vertex Pharmaceuticals 1485100*
Non-sedative barbituric acid derivatives
Taro Pharmaceutical Industries 1485101*
Sequential therapy comprising a 20(S)-camptothecin compound and a pyrimidine base analogue
SuperGen 1485102*
Sulphatase inhibiting continuous progestogen contraceptive regimens
Janssen Pharmaceutica 1485103*
Combination of an aldosterone receptor antagonist and nicotinic acid derivatives
Pharmaceutica Corp 1485104*
Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
Pharmacia Corp Corporate Patent Department 1485105*
Phosphonate-phosphate and diphosphonate apolipoprotein E modulators
Ilex Products 1485106*
Phospholipids as caspase inhibitor prodrugs
Vertex Pharmaceuticals 1485107*
Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
Syngenta Participations 1485108*
Vascular therapeutics
Unisearch 1485109*
Use of sulphoalkyl ester cyclodextrins as a preservative
Cydex 1485110*
Compsns containing labile bioactive materials and mammalian colostrum, methods of preparation and treatment
Anadis 1485111*
Treatment of surfaces populated by bacteria with a Lucilia sericata extract
The Secretary of State for Defence, DTSL Porton Down 1485112*
Water soluble bioactive fraction isolated from gum resin exudate of Boswellia serrata, process for isolation thereof , compsn containing said fraction and use thereof
Council of Scientific and Industrial Research 1485113*
Isolation, purification and structural identification of a water-soluble extract of a botanical species for enhancing anti-inflammatory, anti-tumour and DNA repair processes of warm blooded animals
Pero, Ronald 1485114*
Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
Nelson, Deanna 1485115*
Angiotensin-(1,7) and angiotensin-(1,7) agonists for inhibition of cancer cell growth
Wake Forest University 1485116*
Methods for therapeutic treatment of benign prostatic hypertrophy (BPH)
New York University 1485117*
Methods and compsns for treating gastrointestinal toxicity induced by cytoablative therapy
Sangstat Medical Corp 1485118*
Enhancing the availability of minerals by using biologically active peptides
Valio 1485119*
Use of one or more natural or modified oxygen carriers, devoid of plasma and cellular membrane constituents, for externally treating open, in particular chronic wounds
SanguiBioTech 1485120*
Activated protein C formulations
Eli LIlly 1485121*
Novel application of vaccination against TNF-alpha
Pharmexa 1485122*
Method of inducing an enhanced immune response against HIV
Merck 1485123*
Method of inducing an enhanced immune response against HIV
Merck 1485124*
Improvements in vaccination
Glaxo Group 1485125*
Administration of agents for the treatment of inflammation
Elan Pharmaceuticals 1485127*
Nanostructures containing antibody assembly units
Nanoframes 1485128*
Nanostructures containing pilin protein
Nanoframes 1485129*
Reagents and treatment methods for autoimmune diseases
Duke University 1485130*
Matrix metalloproteinase inhibitors in combination with hypothermia and/or radiotherapy for the treatment of cancer
Novartis 1485131*
Combination of an aldosterone receptor antagonist and a fibric acid derivative
Pharmacia 1485132*
Medical device for delivering biologically active material
Scimed Life Systems 1485138*
Biomatrix and method for producing the same
Ars Arthro 1485139*
Polymer composite loaded with cells
The University of Nottingham 1485140*
1,2-dihydropyrazol-3-ones as cytokine mediators
Procter & Gamble 1485167*
Combination of a CDK inhibitor and 5-FU for the treatment of cancer
Cyclacel 1485168*
Amorphous HMG-CoA reductase inhibitors of desired particle size
Biocon 1485343*
Venlafaxine besylate
Synthon 1485344*
Urokinase inhibitors, production and use thereof
Curacyte 1485345*
Novel positively charged lipids and liposomes comprising the positively charged lipids
Yonsei University 1485346*
HIF hydroxylated inhibitors
Isis Innovation 1485347*
Carbonylamino-derivatives as novel inhibitors of histone deacetylase
Janssen Pharmaceutica 1485348*
Formulations of anthraquinone derivatives
BTG International 1485349*
Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams
Bristol-Myers Squibb 1485351*
Azaspiro compounds for the treatment of pain
Schwarz Pharma 1485352*
New inhibitors of histone deacylase
Janssen Pharmaceutica 1485353*
Sulphonylamino-derivatives as novel inhibitors of histone deacetylase
Janssen Pharmaceutica 1485354*
Pyridinyl amides and compsns thereof for use as fungicides
E I duPont de Nemours 1485355*
Non-peptides GNRH antagonists
Ferring 1485356*
Process for asymmetric hydrogenation of hexahydroquinoline salts
DSM 1485357*
Broad spectrum substituted benzimidazole sulphonamide HIV protease inhibitors
Tibotec Pharmaceuticals 1485358*
